Nippon Organon to Release Recombinant Follicle Stimulating Hormone Follistim.Tokyo, Japan, Aug 8, 2005 - (JCNN JCNN Japan Corporate News Network ) - Nippon Organon will launch Follistim 75 and Follistim 150, its proprietary recombinant follicle stimulating hormone Follicle stimulating hormone (FSH) A hormone that stimulates the growth and maturation of mature eggs in the ovary. Mentioned in: Polycystic Ovary Syndrome, Premature Menopause (FSH FSH follicle-stimulating hormone. FSH abbr. follicle-stimulating hormone Facioscapulohumeral muscular dystrophy (FSH) ) products used in assisted reproductive treatment, on August 11. The new products will be the first recombinant FSH agents to be marketed in Japan. Compared to the conventional urine-derived FSH agent, Follistim has a purity of 99% and improves the pregnancy rate. The new products are not to be covered by the National Health Insurance. Source: JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) http://www.japancorp.net Copyright [c] 2005 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion